RankingsPricing
  1. US-listed companies
  2. Merck & Co., Inc.
  3. Financials
  4. Research & development

Merck & Co., Inc.MRK

Market cap
$251.9B
P/E ratio
SummaryFinancials
Period EndResearch & development (Million USD)YoY (%)
Dec 31, 202417,938-41.25%
Dec 31, 202330,531+125.35%
Dec 31, 202213,548+10.64%
Dec 31, 202112,245-9.68%
Dec 31, 202013,558+37.34%
Dec 31, 20199,872+1.23%
Dec 31, 20189,752-4.47%
Dec 31, 201710,208+0.83%
Dec 31, 201610,124+51.01%
Dec 31, 20156,704-6.63%
Dec 31, 20147,180-4.30%
Dec 31, 20137,503-8.14%
Dec 31, 20128,168-3.53%
Dec 31, 20118,467-22.96%
Dec 31, 201010,991

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)